Evidence map›Paper›PMID 33287416›Full record

ReviewInternational journal of molecular sciences2020

Bacterial Metabolites of Human Gut Microbiota Correlating with Depression.

Olga V Averina, Yana A Zorkina, Roman A Yunes, Alexey S Kovtun, Valeriya M Ushakova, Anna Y Morozova, George P Kostyuk, Valery N Danilenko, Vladimir P Chekhonin

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Olga V AverinaVavilov Institute of General Genetics, Russion Academy of Sciences, 119991 Moscow, Russia.
Yana A ZorkinaVavilov Institute of General Genetics, Russion Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0003-0247-2717
Roman A YunesVavilov Institute of General Genetics, Russion Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0001-6283-6258
Alexey S KovtunVavilov Institute of General Genetics, Russion Academy of Sciences, 119991 Moscow, Russia.
Valeriya M UshakovaDepartment Basic and Applied Neurobiology, V.P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, Russia.
Anna Y MorozovaDepartment Basic and Applied Neurobiology, V.P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, Russia.
George P KostyukMental-Health Clinic No. 1 Named after N.A. Alexeev of Moscow Healthcare Department, 117152 Moscow, Russia.
Valery N DanilenkoVavilov Institute of General Genetics, Russion Academy of Sciences, 119991 Moscow, Russia.
Vladimir P ChekhoninDepartment Basic and Applied Neurobiology, V.P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, Russia.

Funding

Russian Science Foundation 20-14-00132
6 · The paper itself

Abstract

Depression is a global threat to mental health that affects around 264 million people worldwide. Despite the considerable evolution in our understanding of the pathophysiology of depression, no reliable biomarkers that have contributed to objective diagnoses and clinical therapy currently exist. The discovery of the microbiota-gut-brain axis induced scientists to study the role of gut microbiota (GM) in the pathogenesis of depression. Over the last decade, many of studies were conducted in this field. The productions of metabolites and compounds with neuroactive and immunomodulatory properties among mechanisms such as the mediating effects of the GM on the brain, have been identified. This comprehensive review was focused on low molecular weight compounds implicated in depression as potential products of the GM. The other possible mechanisms of GM involvement in depression were presented, as well as changes in the composition of the microbiota of patients with depression. In conclusion, the therapeutic potential of functional foods and psychobiotics in relieving depression were considered. The described biomarkers associated with GM could potentially enhance the diagnostic criteria for depressive disorders in clinical practice and represent a potential future diagnostic tool based on metagenomic technologies for assessing the development of depressive disorders.

Indexed as

Gastrointestinal MicrobiomeAmino AcidsBacteriaBiomarkersBrainDepressionDisease SusceptibilityEnergy MetabolismFunctional FoodHumansNeurotransmitter AgentsAmino AcidsBiomarkersNeurotransmitter Agentsaminoacidsbiomarkersdepressionfunctional foodsgut-brain axisgut microbiotaneurotransmitterspsychobiotics

Identifiers

PMID33287416
PMCPMC7730936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.